Showing results (581-590 of 6,991) with videos related to
Sort By:
Pageof 700
Cancer Science|September 3, 2016
Germline PMS2 mutation screened by mismatch repair protein immunohistochemistry of colorectal cancer in JapanKokichi Sugano, Takeshi Nakajima, Shigeki Sekine, et al.Cancer Science|September 3, 2016
High expression of the Notch ligand Jagged-1 is associated with poor prognosis after surgery for colorectal cancerMasakazu Sugiyama, Eiji Oki, Yu Nakaji, et al.Cancer Science|March 10, 2010
Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatinMasaki Shiota, Akira Yokomizo, Eiji Kashiwagi, et al.Cancer Science|August 27, 2016
An IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphomaHasita Horlad, Chaoya Ma, Hiromu Yano, et al.Cancer Science|August 28, 2016
Pharmacologic study (JP28927) of alectinib in Japanese patients with ALK+ non-small-cell lung cancer with or without prior crizotinib therapyToyoaki Hida, Kazuhiko Nakagawa, Takashi Seto, et al.Cancer Science|April 7, 2018
eIF2β, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancerIchidai Tanaka, Mitsuo Sato, Toshio Kato, et al.Cancer Science|July 11, 2017
Heat shock protein 70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cellsKazuaki Kita, Masayuki Shiota, Masako Tanaka, et al.Cancer Science|April 17, 2018
Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcomaHideaki Tsuyoshi, Yoshio YoshidaCancer Science|April 17, 2018
High G2 and S-phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosisTianxiao Xu, Meng Ma, Zhihong Chi, et al.Cancer Science|April 17, 2018
Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogeninShuya Kandori, Takahiro Kojima, Taeko Matsuoka, et al.Pageof 700